Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Revision as of 14:57, 27 July 2012 by Raviteja Reddy Guddeti (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Articles

Most recent articles on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Most cited articles on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Review articles on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Articles on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Images of Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Photos of Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Podcasts & MP3s on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Videos on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Evidence Based Medicine

Cochrane Collaboration on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Bandolier on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

TRIP on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Clinical Trials

Ongoing Trials on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency at Clinical Trials.gov

Trial results on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Clinical Trials on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

NICE Guidance on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

NHS PRODIGY Guidance

FDA on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

CDC on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Books

Books on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

News

Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency in the news

Be alerted to news on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

News trends on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Commentary

Blogs on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Definitions

Definitions of Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Patient Resources / Community

Patient resources on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Discussion groups on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Patient Handouts on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Directions to Hospitals Treating Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Risk calculators and risk factors for Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Healthcare Provider Resources

Symptoms of Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Causes & Risk Factors for Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Diagnostic studies for Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Treatment of Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Continuing Medical Education (CME)

CME Programs on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

International

Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency en Espanol

Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency en Francais

Business

Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency in the Marketplace

Patents on Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Experimental / Informatics

List of terms related to Xylosylprotein 4-beta-galactosyltransferase (XGPT) deficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Synonyms and keywords: Ehler's Danlos syndrome - progeroid form

Overview

Xylosylprotein 4-beta-galactosyltransferase deficiency is a variant of Ehlers-Danlos syndrome.

Pathophysiology

This disease is caused by mutation in the gene encoding xylosylprotein 4-beta-galactosyltransferase, which catalyzes the second glycosyl transfer reaction in the assembly of the dermatan sulfate chain, leading to defective synthesis of proteodermatan sulfate (PDS).

Diagnosis

Symptoms

  • Wrinkling of the skin over the face
  • Delayed wound healing

Physical examination

Appearance of the patient

Patients with this disease are short statured with an aged appearance.

Skin

  • Loose but elastic skin
  • Scanty scalp hair

Head

  • Defective deciduous teeth
  • Wrinkled facies

Neurologic

Extremities

  • Hypermobile joints
  • Hypotonic muscles

X-ray


References



Template:WH Template:WS